Volume 8, Issue 5, Pages (May 2009)

Slides:

Advertisements

Similar presentations

Crohn's disease Prof Daniel C Baumgart, MD, Prof William J Sandborn, MD The Lancet Volume 380, Issue 9853, Pages (November 2012) DOI: /S (12)

Advertisements

Volume 376, Issue 9753, Pages (November 2010)

Volume 370, Issue 9586, Pages (August 2007)

Enhanced performance feedback and patient participation to improve hand hygiene compliance of health-care workers in the setting of established multimodal.

Volume 348, Issue 9035, Pages (October 1996)

Volume 367, Issue 9517, Pages (April 2006)

Volume 375, Issue 9729, Pages (May 2010)

Pharmacogenetics and future drug development and delivery

Volume 8, Issue 10, Pages (October 2009)

Volume 11, Issue 4, Pages (April 2012)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.

Volume 16, Issue 9, Pages (September 2015)

Volume 373, Issue 9660, Pages (January 2009)

Volume 378, Issue 9785, Pages (July 2011)

Volume 376, Issue 9734, Pages (July 2010)

Volume 17, Issue 2, Pages (February 2016)

Thank God for Richard Dawkins?

Volume 380, Issue 9836, Pages (July 2012)

Long-term effects of hormone replacement therapy

Meta-analysis of randomised controlled trials

Volume 5, Issue 4, Pages (April 2006)

Volume 389, Issue 10076, Pages (April 2017)

Volume 376, Issue 9734, Pages (July 2010)

Volume 9, Issue 5, Pages (May 2008)

Volume 366, Issue 9482, Pages (July 2005)

Long-term effects of hormone replacement therapy

Volume 376, Issue 9746, Pages (September 2010)

Volume 366, Issue 9486, Pages (August 2005)

Volume 14, Issue 4, Pages (April 2015)

Volume 12, Issue 9, Pages (September 2013)

Volume 373, Issue 9677, Pages (May 2009)

Volume 15, Issue 4, Pages (April 2014)

Aspirin in the prevention of cancer – Author's reply

Volume 366, Issue 9482, Pages (July 2005)

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised.

Volume 2, Issue 6, Pages (June 2015)

A next-generation Alzheimer's centre for Madrid

Incident diabetes in clinical trials of antihypertensive drugs

Volume 9, Issue 9, Pages (September 2010)

Volume 378, Issue 9801, Pages (October 2011)

Volume 375, Issue 9732, Pages (June 2010)

Volume 385, Issue 9969, Pages (February 2015)

Volume 15, Issue 1, Pages (January 2014)

Volume 378, Issue 9785, Pages (July 2011)

Volume 16, Issue 1, Pages (January 2017)

Volume 373, Issue 9660, Pages (January 2009)

Volume 14, Issue 11, Pages (October 2013)

Volume 373, Issue 9666, Pages (March 2009)

Volume 371, Issue 9625, Pages (May 2008)

Volume 372, Issue 9647, Pages (October 2008)

Volume 376, Issue 9753, Pages (November 2010)

Volume 371, Issue 9627, Pages (May 2008)

Volume 378, Issue 9786, Pages (July 2011)

Volume 9, Issue 4, Pages (April 2008)

C-reactive protein concentration and the vascular benefits of statin therapy: an analysis of 20 536 patients in the Heart Protection Study Heart Protection.

Volume 375, Issue 9726, Pages (May 2010)

Thank God for Richard Dawkins?

Department of Error The Lancet Volume 369, Issue 9564, (March 2007)

Low-technology approaches

Volume 384, Issue 9957, Pages (November 2014)

Volume 375, Issue 9719, Pages (March 2010)

Volume 375, Issue 9714, Pages (February 2010)

Volume 11, Issue 3, Pages (March 2010)

Volume 11, Issue 1, Pages (January 2010)

Volume 371, Issue 9618, Pages (March 2008)

Volume 13, Issue 7, Pages (July 2014)

Volume 8, Issue 10, Pages (October 2009)

Clinic attendance and disengagement of young adults with type 1 diabetes after transition of care from paediatric to adult services (TrACeD): a randomised,

Effect of consent rituals on mortality in emergency care research

Volume 17, Issue 2, Pages (February 2016)

Presentation transcript:

Volume 8, Issue 5, Pages 427-433 (May 2009) Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial (ISAT): long-term follow-up Andrew J Molyneux, FRCR, Richard SC Kerr, FRCS, Jacqueline Birks, MSc, Najib Ramzi, MD, Julia Yarnold, MA, Mary Sneade, BA, Joan Rischmiller, RGN The Lancet Neurology Volume 8, Issue 5, Pages 427-433 (May 2009) DOI: 10.1016/S1474-4422(09)70080-8 Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 1 Study profile *Some non-UK centres no longer follow-up patients. †Lost patients had moved abroad (from country of randomisation) or had had no contact with study centre or primary-care physician since the first or second year of study. ‡Patient has withdrawn or they no longer wish to participate. The Lancet Neurology 2009 8, 427-433DOI: (10.1016/S1474-4422(09)70080-8) Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 2 Kaplan–Meier graph of cumulative risk of rebleed from the treated aneurysm after more than 1 year by treatment allocation Patients followed up for a minimum of 6 years and a maximum of 14 years. SAH=subarachnoid haemorrhage. The Lancet Neurology 2009 8, 427-433DOI: (10.1016/S1474-4422(09)70080-8) Copyright © 2009 Elsevier Ltd Terms and Conditions

Figure 3 Kaplan–Meier graph of cumulative mortality rate Patients followed up for a minimum of 6 years and a maximum of 14 years. SAH=subarachnoid haemorrhage. The Lancet Neurology 2009 8, 427-433DOI: (10.1016/S1474-4422(09)70080-8) Copyright © 2009 Elsevier Ltd Terms and Conditions